ES2058283T3 - Vacuna contra coronavirus canino. - Google Patents

Vacuna contra coronavirus canino.

Info

Publication number
ES2058283T3
ES2058283T3 ES88305190T ES88305190T ES2058283T3 ES 2058283 T3 ES2058283 T3 ES 2058283T3 ES 88305190 T ES88305190 T ES 88305190T ES 88305190 T ES88305190 T ES 88305190T ES 2058283 T3 ES2058283 T3 ES 2058283T3
Authority
ES
Spain
Prior art keywords
canine coronavirus
vaccine against
cellular
against canine
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88305190T
Other languages
English (en)
Inventor
Michael Alonzo Gill
Stephen Wayne May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Application granted granted Critical
Publication of ES2058283T3 publication Critical patent/ES2058283T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REIFIERE A UNA VACUNA DE CORONAVIRUS CANINE (CCV) DE UN ANTIGENO PEPLOMERO ASOCIADO A CELULAS, PROCESOS PARA PREPARAR TAL VACUNA, VACUNAS POLIVALENTES CONSISTENTES EN ANTIGENO PEPLOMERO CCV ASOCIADO A CELULAS EN ASOCIACION CON UNO O MAS ORGANISMOS O VIRUS PATOGENOS ADICIONALES, Y USO DE LAS VACUNAS ARRIBA MENCIONADAS EN LA PROFILAXIS DE INFECCION CAUSADA POR CCV.
ES88305190T 1987-06-08 1988-06-07 Vacuna contra coronavirus canino. Expired - Lifetime ES2058283T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (1)

Publication Number Publication Date
ES2058283T3 true ES2058283T3 (es) 1994-11-01

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88305190T Expired - Lifetime ES2058283T3 (es) 1987-06-08 1988-06-07 Vacuna contra coronavirus canino.

Country Status (20)

Country Link
US (1) US4904468A (es)
EP (1) EP0295057B1 (es)
JP (1) JP2655876B2 (es)
KR (1) KR970000233B1 (es)
AT (1) ATE91902T1 (es)
AU (1) AU612151B2 (es)
CA (1) CA1337267C (es)
DE (1) DE3882599T2 (es)
DK (1) DK175410B1 (es)
ES (1) ES2058283T3 (es)
FI (1) FI87531C (es)
HU (1) HU203984B (es)
IE (1) IE63006B1 (es)
IL (1) IL86635A0 (es)
MY (1) MY103575A (es)
NO (1) NO176004C (es)
NZ (1) NZ224865A (es)
PH (1) PH27018A (es)
PT (1) PT87668B (es)
ZA (1) ZA884040B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
ZA903142B (en) * 1989-05-03 1991-02-27 Akzo Nv Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
JPH05506233A (ja) * 1990-04-24 1993-09-16 フラスタット・ピーティーワイ・リミテッド 赤血球の表面に結合した抗原を含むワクチン
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
EP0510773B1 (en) * 1991-04-25 2003-12-17 Akzo Nobel N.V. Canine coronavirus subunit vaccine
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
JP3245169B2 (ja) * 1992-05-08 2002-01-07 ファイザー・インコーポレイテッド イヌ・コロナウイルスｓ遺伝子およびその使用
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
EP1780216B1 (en) * 2005-10-26 2010-12-29 Canio Buonavoglia Pantropic canine coronavirus
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
CA2777692A1 (en) * 2009-10-14 2011-04-21 Sanjay Kapil Isolation of a virus related to canine parvovirus-2 from a raccoon
SG11201503854UA (en) 2012-11-22 2015-06-29 Asahi Kasei Medical Co Ltd Method for producing parvovirus having high infectivity titer
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
KR102036467B1 (ko) 2015-11-06 2019-10-24 아사히 가세이 메디컬 가부시키가이샤 고감염가 또한 고순도의 파보바이러스의 생산 방법
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
EP0218625B1 (en) * 1985-03-29 1995-04-05 Btg International Limited Infectious bronchitis virus spike protein

Also Published As

Publication number Publication date
PT87668B (pt) 1992-09-30
NO882500L (no) 1988-12-09
KR970000233B1 (ko) 1997-01-08
AU612151B2 (en) 1991-07-04
EP0295057A2 (en) 1988-12-14
KR890000105A (ko) 1989-03-11
HU203984B (en) 1991-11-28
MY103575A (en) 1993-08-28
IL86635A0 (en) 1988-11-30
FI882689A (fi) 1988-12-09
NO882500D0 (no) 1988-06-07
NO176004B (no) 1994-10-10
EP0295057A3 (en) 1989-12-27
NO176004C (no) 1995-01-18
HUT46858A (en) 1988-12-28
PH27018A (en) 1993-02-01
EP0295057B1 (en) 1993-07-28
FI882689A0 (fi) 1988-06-07
NZ224865A (en) 1990-12-21
ZA884040B (en) 1989-09-27
AU1747688A (en) 1988-12-08
DE3882599D1 (de) 1993-09-02
CA1337267C (en) 1995-10-10
DK301588D0 (da) 1988-06-02
IE63006B1 (en) 1995-03-22
IE881689L (en) 1988-12-08
PT87668A (pt) 1988-07-01
US4904468A (en) 1990-02-27
JPS63316739A (ja) 1988-12-26
FI87531B (fi) 1992-10-15
DE3882599T2 (de) 1994-02-10
DK175410B1 (da) 2004-09-27
JP2655876B2 (ja) 1997-09-24
DK301588A (da) 1988-12-09
ATE91902T1 (de) 1993-08-15
FI87531C (fi) 1993-01-25

Similar Documents

Publication Publication Date Title
ES2058283T3 (es) Vacuna contra coronavirus canino.
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
BR9814606A (pt) Formulação de vacina e métodos de tratamento de um indivìduo infectado com um vìrus hpv e de prevenção de infecção por papiloma vìrus
ES2170234T3 (es) Vacuna contra el virus prrs (sindrome reproductor y respiratorio porcino).
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
ES2136088T3 (es) Compuestos inmunogenos con efecto principalmente anti-citoquina, procedimiento de preparacion, composiciones farmaceuticas y kits que los contienen.
ATE230798T1 (de) Rekombinanter herpes simplex gb-gd-impfstoff
BR0209161A (pt) Composição de vacina, kit de vacinação, método de tratamento médico, uso de um antìgeno de hpv, e, métodos para preparar uma vacina e para diminuir a transmissão viral do hiv
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
ES8201020A1 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
ES2000435T3 (es) Procedimiento de purificacion de antigenos proteinicos de bacterias que pertenecen al genero bordetella, en vista a la obtencion de una vacuna acelular.
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
DK56389D0 (da) Forhindring og behandling af retroviralt frembragte sygdomme
ES2166763T3 (es) Inmunizacion parenteral contra rotavirus.
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
ES2055687T3 (es) Vacuna de virus.
FI893346A (fi) Icke-reverterande rna-virus.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295057

Country of ref document: ES